Multifunctional proteins in tumorigenesis: Aminoacyl-tRNA synthetases and translational components

Current Proteomics

Volumn 3, Issue 4, 2006, Pages 233-247

  Sang, Won Lee ^a   Young, Sun Kang ^b   Kim, Sunghoon ^c  

^a Seoul National University of Education   (South Korea)

^b Konkuk University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Aminoacyl tRNA synthetase; Cell transformation; Malignant phenotype; Multi functionality; Ribosomal protein; Translation; Translation elongation factor; Translation initiation factor; Translation releasing factor

Indexed keywords

EUKARYOTA;

EID: 34248344105     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016406780655577     Document Type: Review

References (208)

1. Abbott, C.M. and Proud, C.G. (2004). Translation factors: in sickness and in health. Trends Biochem. Sci. 29: 25-31.
2. Amsterdam, A., Sadler, K.C., Lai, K., Farrington, S., Bronson, R.T., Lees, J.A. and Hopkins, N. (2004). Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2: E139.
3. Baisch, H. (2002). Elevated Ki-67 expression is correlated with TNFalpha-and IFNgamma-induced apoptosis in tumour cells. Cell Prolif. 35: 333-42.
4. Barnett, G., Jakobsen, A.M., Tas, M., Rice, K., Carmichael, J. and Murray, J. C. (2000). Prostate adenocarcinoma cells release the novel proinflammatory polypeptide EMAP-II in response to stress. Cancer Res. 60: 2850-57.
5. Beckwith, J.B. (1983). Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center. Hum. Pathol. 14: 481-92.
6. Bergqvist, M., Brattstrom, D., Brodin, D., Lindkvist, A., Dahlman-Wright, K., Dreilich, M., Wagenius, G. and Paulsson-Karlsson, Y. (2006). Genes associated with telomerase activity levels in esophageal carcinoma cell lines. Dis. Esophagus. 19: 20-3.
7. Bertram, J., Palfner, K., Hiddemann, W. and Kneba, M. (1998). Overexpression of ribosomal proteins L4 and L5 and the putative alternative elongation factor PTI-1 in the doxorubicin resistant human colon cancer cell line LoVoDxR. Eur. J. Cancer 34: 731-6.
8. Boon, K., Caron, H.N., van Asperen, R., Valentijn, L., Hermus, M.C., van Sluis, P., Roobeek, I., Weis, I., et al. (2001). N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J. 20: 1383-93.
9. Bottoni, A., Piccin, D., Tagliati, F., Luchin, A., Zatelli, M.C. and degli Uberti, E.C. (2005). miR-15a and miR-16-1 down-regulation in pituitary adenomas. J. Cell Physiol. 204: 280-5.
10. Boultwood, J., Fidler, C., Lewis, S., Kelly, S., Sheridan, H., Littlewood, T.J., Buckle, V.J. and Wainscoat, J.S. (1994). Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q-syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint. Genomics 19: 425-32.
11. Bridge, J.A., Kanamori, M., Ma, Z., Pickering, D., Hill, D.A., Lydiatt, W., Lui, M.Y., Colleoni, G.W., et al. (2001). Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am. J. Pathol. 159: 411-5.
12. Brito, M., Malta-Vacas, J., Carmona, B., Aires, C., Costa, P., Martins, A.P., Ramos, S., Conde, A.R., et al. (2005). Polyglycine expansions in eRF3/GSPT1 are associated with gastric cancer susceptibility. Carcinogenesis 26: 2046-9.
13. Bruhat, A., Jousse, C., Wang, X.Z., Ron, D., Ferrara, M. and Fafournoux, P. (1997). Amino acid limitation induces expression of CHOP, a CCAAT/enhancer binding protein-related gene, at both transcriptional and post-transcriptional levels. J. Biol. Chem. 272: 17588-93.
14. Budde, A. and Grummt, I. (1999). p53 represses ribosomal gene transcription. Oncogene 18: 1119-24.
15. Buim, M.E., Soares, F.A., Sarkis, A.S. and Nagai, M.A. (2005). The transcripts of SFRP1,CEP63 and EIF4G2 genes are frequently downregulated in transitional cell carcinomas of the bladder. Oncology 69: 445-54.
16. Burks, E.A., Bezerra, P.P., Le, H., Gallie, D.R. and Browning, K.S. (2001). Plant initiation factor 3 subunit composition resembles mammalian initiation factor 3 and has a novel subunit. J. Biol. Chem. 276: 2122-31.
17. Buttitta, F., Martella, C., Barassi, F., Felicioni, L., Salvatore, S., Rosini, S., D'Antuono, T., Chella, A., et al. (2005). Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Clin. Cancer Res. 11: 3198-204.
18. Caraglia, M., Budillon, A., Vitale, G., Lupoli, G., Tagliaferri, P. and Abbruzzese, A. (2000). Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation. Eur. J. Biochem. 267: 3919-36.
19. Castresana, J.S., Barrios, C., Gomez, L. and Kreicbergs, A. (1992). Amplification of the c-myc proto-oncogene in human chondrosarcoma. Diagn. Mol. Pathol. 1: 235-8.
20. Chan, Y.L., Diaz, J.J., Denoroy, L., Madjar, J.J. and Wool, I.G. (1996). The primary structure of rat ribosomal protein L10: relationship to a Junbinding protein and to a putative Wilms' tumor suppressor. Biochem. Biophys. Res. Commun. 225: 952-6.
21. Chatterjee, M., Mohapatra, S., Ionan, A., Bawa, G., Ali-Fehmi, R., Wang, X., Nowak, J., Ye, B., et al. (2006). Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res. 66: 1181-90.
22. Chen, G., Gharib, T.G., Thomas, D.G., Huang, C.C., Misek, D.E., Kuick, R.D., Giordano, T.J., Iannettoni, M.D., et al. (2003). Proteomic analysis of eIF-5A in lung adenocarcinomas. Proteomics 3: 496-504.
23. Cher, M.L., Bova, G.S., Moore, D.H., Small, E.J., Carroll, P.R., Pin, S.S., Epstein, J.I., Isaacs, W.B., et al. (1996). Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res. 56: 3091-102.
24. Chintharlapalli, S.R., Jasti, M., Malladi, S., Parsa, K.V., Ballestero, R.P. and Gonzalez-Garcia, M. (2005). BMRP is a Bcl-2 binding protein that induces apoptosis. J. Cell Biochem. 94: 611-26.
25. Clemens, M.J. (2004). Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 23: 3180-8.
26. Clemens, M.J. and Bommer, U.A. (1999). Translational control: the cancer connection. Int. J. Biochem. Cell Biol. 31: 1-23.
27. Clement, P.M., Henderson, C.A., Jenkins, Z.A., Smit-McBride, Z., Wolff, E.C., Hershey, J.W., Park, M.H. and Johansson, H.E. (2003). Identification and characterization of eukaryotic initiation factor 5A-2. Eur. J. Biochem. 270: 4254-63.
28. Coller, H.A., Grandori, C., Tamayo, P., Colbert, T., Lander, E.S., Eisenman, R.N. and Golub, T.R. (2000). Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. USA 97: 3260-5.
29. Cook, J.R., Dehner, L.P., Collins, M.H., Ma, Z., Morris, S.W., Coffin, C.M. and Hill, D.A. (2001). Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am. J. Surg. Pathol. 25: 1364-71.
30. Cools, J., Wlodarska, I., Somers, R., Mentens, N., Pedeutour, F., Maes, B., De Wolf-Peeters, C., Pauwels, P., et al. (2002). Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 34: 354-62.
31. Cruzen, M.E., Bengtsson, U., McMahon, J., Wasmuth, J.J. and Arfin, S.M. (1993). Brief report - assignment of the cysteinyl tRNA synthetase gene (CARS) to 11p15.5. Genomics 15: 692-3.
32. Dai, M.S., Zeng, S.X., Jin, Y., Sun, X.X., David, L. and Lu, H. (2004). Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol. Cell Biol. 24: 7654-68.
33. De Benedetti, A. and Graff, J.R. (2004). eIF-4E expression and its role in malignancies and metastases. Oncogene 23: 3189-99.
34. De Benedetti, A. and Harris, A.L. (1999). eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Cell Biol. 31: 59-72.
35. Debelenko, L.V., Arthur, D.C., Pack, S.D., Helman, L.J., Schrump, D.S. and Tsokos, M. (2003). Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Lab. Invest. 83: 1255-65.
36. DeFatta, R.J., Turbat-Herrera, E.A., Li, B.D., Anderson, W. and De Benedetti, A. (1999). Elevated expression of eIF4E in confined early breast cancer lesions: possible role of hypoxia. Int. J. Cancer 80: 516-22.
37. Deniziak, M.A. and Barciszewski, J. (2001). Methionyl-tRNA synthetase. Acta. Biochim. Pol. 48: 337-50.
38. Dong, Z., Liu, L.H., Han, B., Pincheira, R. and Zhang, J.T. (2004). Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth. Oncogene 23: 3790-801.
39. Du, J.P., Jin, X.H., Shi, Y.Q., Cao, Y.X., Zhao, Y.Q., Liu, C.J., Yin, F., Hu, W.H., et al. (2003). Differential expression of RPL6/Taxreb107 in drug resistant gastric cancer cell line SGC7901/ADR and its correlation with multiple-drug resistance. Zhonghua Zhong Liu Za Zhi 25: 21-5.
40. Dubourg, C., Toutain, B., Helias, C., Henry, C., Lessard, M., Le Gall, J.Y., Le Treut, A. and Guenet, L. (2002). Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene. Cancer Genet. Cytogenet. 134: 33-7.
41. Duyster, J., Bai, R.Y. and Morris, S.W. (2001). Translocations involving anaplastic lymphoma kinase (ALK). Oncogene 20: 5623-37.
42. Eberle, J., Fecker, L.F., Bittner, J.U., Orfanos, C.E. and Geilen, C.C. (2002). Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4A1. Br. J. Cancer 86: 1957-62.
43. Eberle, J., Krasagakis, K. and Orfanos, C.E. (1997). Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int. J. Cancer 71: 396-401.
44. Ejiri, S. (2002). Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization. Biosci. Biotechnol. Biochem. 66: 1-21.
45. Fan, X., Paetau, A., Aalto, Y., Valimaki, M., Sane, T., Poranen, A., Castresana, J.S. and Knuutila, S. (2001). Gain of chromosome 3 and loss of 13q are frequent alterations in pituitary adenomas. Cancer Genet. Cytogenet. 128: 97-103.
46. Fingar, D.C., Richardson, C.J., Tee, A.R., Cheatham, L., Tsou, C. and Blenis, J. (2004). mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell Biol. 24: 200-16.
47. Fleckner, J., Martensen, P.M., Tolstrup, A.B., Kjeldgaard, N.O. and Justesen, J. (1995). Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 7: 70-7.
48. Fontoura, B.M., Sorokina, E.A., David, E. and Carroll, R.B. (1992). p53 is covalently linked to 5.8S rRNA. Mol. Cell Biol. 12: 5145-51.
49. Forozan, F., Mahlamaki, E.H., Monni, O., Chen, Y., Veldman, R., Jiang, Y., Gooden, G.C., Ethier, S.P., et al. (2000). Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 60: 4519-25.
50. Forus, A., Florenes, V.A., Maelandsmo, G.M., Fodstad, O. and Myklebost, O. (1994). The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas. Cancer Genet. Cytogenet. 78: 165-71.
51. Francia, G., Man, S., Teicher, B., Grasso, L. and Kerbel, R.S. (2004). Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents. Mol Cell. Biol. 24: 6837-49.
52. Galasinski, W. and Moldave, K. (1969). Purification of aminoacyltransferase II(translocation factor) from rat liver. J. Biol. Chem. 244: 6527-32.
53. Gicquel, C., Raffin-Sanson, M.L., Gaston, V., Bertagna, X., Plouin, P.F., Schlumberger, M., Louvel, A., Luton, J.P., et al. (1997). Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J. Clin. Endocrinol. Metab. 82: 2559-65.
54. Gopalkrishnan, R.V., Su, Z.Z., Goldstein, N.I. and Fisher, P.B. (1999). Translational infidelity and human cancer: role of the PTI-1 oncogene. Int. J. Biochem. Cell Biol. 31: 151-62.
55. Graff, J.R., Boghaert, E.R., De Benedetti, A., Tudor, D.L., Zimmer, C.C., Chan, S.K. and Zimmer, S.G. (1995). Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts. Int. J. Cancer 60: 255-63.
56. Gray, N.K. and Wickens, M. (1998). Control of translation initiation in animals. Annu. Rev. Cell. Dev. Biol. 14: 399-458.
57. Griffin, C.A., Hawkins, A.L., Dvorak, C., Henkle, C., Ellingham, T. and Perlman, E.J. (1999). Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res. 59: 2776-80.
58. Guan, X.Y., Fung, J.M., Ma, N.F., Lau, S.H., Tai, L.S., Xie, D., Zhang, Y., Hu, L., et al. (2004). Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res. 64: 4197-200.
59. Guan, X.Y., Sham, J.S., Tang, T.C., Fang, Y., Huo, K.K. and Yang, J.M. (2001). Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res. 61: 3806-9.
60. Guenet, L., Henry, C., Toutain, B., Dubourg, C., Le Gall, J.Y., David, V. and Le Treut, A. (2000). Eukaryotic translation termination factor gene (ETF1/eRF1) maps at D5S500 in a commonly deleted region of chromosome 5q31 in malignant myeloid diseases. Cytogenet. Cell Genet. 88: 82-6.
61. Hake, L.E. and Richter, J.D. (1997). Translational regulation of maternal mRNA. Biochim. Biophys. Acta 1332: M31-8.
62. Han, J.M., Lee, M.J., Park, S.G., Lee, S.H., Razin, E., Choi, E.C. and Kim, S. (2006). Hierarchical Network between the Components of the Multi-tRNA Synthetase Complex: Implications for Complex Formation. J. Biol. Chem. 281: 38663-7.
63. Hanauske-Abel, H.M., Hanauske, A.R., Slowinska, B. and Popowicz, A.M. (2002). The cell cycle-controlling protein eIF-5A: Identification of functional regions relevant for interaction with mRNA partners. FASEB J. 16: A702.
64. Hemmer, S., Wasenius, V.M., Knuutila, S., Franssila, K. and Joensuu, H. (1999). DNA copy number changes in thyroid carcinoma. Am. J. Pathol. 154: 1539-47.
65. Henis-Korenblit, S., Shani, G., Sines, T., Marash, L., Shohat, G. and Kimchi, A. (2002). The caspase-cleaved DAP5 protein supports internal ribosome entry site-mediated translation of death proteins. Proc. Natl. Acad. Sci. USA 99: 5400-5.
66. Hofmann, W., Reichart, B., Ewald, A., Muller, E., Schmitt, I., Stauber, R.H., Lottspeich, F., Jockusch, B.M., et al. (2001). Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin. J. Cell Biol. 152: 895-910.
67. Holland, E.C. (2004). Regulation of translation and cancer. Cell Cycle 3: 452-5.
68. Hornigold, N., Devlin, J., Davies, A.M., Aveyard, J.S., Habuchi, T. and Knowles, M.A. (1999). Mutation of the 9q34 gene TSC1 in sporadic bladder cancer. Oncogene 18: 2657-61.
69. Hoshino, S., Hosoda, N., Araki, Y., Kobayashi, T., Uchida, N., Funakoshi, Y. and Katada, T. (1999). Novel function of the eukaryotic polypeptide-chain releasing factor 3 (eRF3/GSPT) in the mRNA degradation pathway. Biochemistry (Mosc) 64: 1367-72.
70. Hu, R.J., Lee, M.P., Connors, T.D., Johnson, L.A., Burn, T.C., Su, K., Landes, G.M. and Feinberg, A.P. (1997). A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes. Genomics 46: 9-17.
71. Hu, Z.B., Minden, M.D., McCulloch, E.A. and Stahl, J. (2000). Regulation of drug sensitivity by ribosomal protein S3a. Blood 95: 1047-55.
72. Huang, X.P., Zhao, C.X., Li, Q.J., Cai, Y., Liu, F.X., Hu, H., Xu, X., Han, Y.L., et al. (2006). Alteration of RPL14 in squamous cell carcinomas and preneoplastic lesions of the esophagus. Gene 366: 161-8.
73. Ibba, M. and Soll, D. (1999). Quality control mechanisms during translation. Science 286: 1893-97.
74. Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., et al. (1997). Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-4.
75. Imataka, H., Olsen, H.S. and Sonenberg, N. (1997). A new translational regulator with homology to eukaryotic translation initiation factor 4G. EMBO J. 16: 817-25.
76. Isola, J.J., Kallioniemi, O.P., Chu, L.W., Fuqua, S.A., Hilsenbeck, S.G., Osborne, C.K. and Waldman, F.M. (1995). Genetic aberrations detected by comparative genomic hybridization predict outcome in nodenegative breast cancer. Am. J. Pathol. 147: 905-11.
77. Ivakhno, S.S. and Kornelyuk, A.I. (2004). Cytokine-like activities of some aminoacyl-tRNA synthetases and auxiliary p43 cofactor of aminoacylation reaction and their role in oncogenesis. Exp. Oncol. 26: 250-5.
78. Jakus, J., Wolff, E.C., Park, M.H. and Folk, J.E. (1993). Features of the spermidine-binding site of deoxyhypusine synthase as derived from inhibition studies. Effective inhibition by bis- and mono-guanylated diamines and polyamines. J. Biol. Chem. 268: 13151-9.
79. Jenkins, Z.A., Haag, P.G. and Johansson, H.E. (2001). Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. Genomics 71: 101-9.
80. Johnsson, A., Zeelenberg, I., Min, Y., Hilinski, J., Berry, C., Howell, S.B. and Los, G. (2000). Identification of genes differentially expressed in association with acquired cisplatin resistance. Br. J. Cancer 83: 1047-54.
81. Joseph, P., Lei, Y.X. and Ong, T.M. (2004). Up-regulation of expression of translation factors - a novel molecular mechanism for cadmium carcinogenesis. Mol. Cell Biochem. 255: 93-101.
82. Joseph, P., Lei, Y.X., Whong, W.Z. and Ong, T.M. (2002). Molecular cloning and functional analysis of a novel cadmium-responsive protooncogene. Cancer Res. 62: 703-7.
83. Kang, H.A. and Hershey, J.W. (1994). Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J. Biol. Chem. 269: 3934-40.
84. Karnik, P., Chen, P., Paris, M., Yeger, H. and Williams, B.R. (1998). Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions. Oncogene 17: 237-40.
85. Kasai, H., Nadano, D., Hidaka, E., Higuchi, K., Kawakubo, M., Sato, T.A. and Nakayama, J. (2003). Differential expression of ribosomal proteins in human normal and neoplastic colorectum. J. Histochem. Cytochem. 51: 567-74.
86. Kaziro, Y., Itoh, H., Kozasa, T., Nakafuku, M. and Satoh, T. (1991). Structure and function of signal-transducing GTP-binding proteins. Annu. Rev. Biochem. 60: 349-400.
87. Keiper, B.D., Gan, W. and Rhoads, R.E. (1999). Protein synthesis initiation factor 4G. Int. J. Biochem. Cell Biol. 31: 37-41.
88. Kerr, B., Mucchielli, M.L., Sigaudy, S., Fabre, M., Saunier, P., Voelckel, M.A., Howard, E., Elles, R., et al. (2003). Is the locus for Costello syndrome on 11p? J. Med. Genet. 40: 469-71.
89. Kim, J.Y., Kang, Y.S., Lee, J.W., Kim, H.J., Ahn, Y.H., Park, H., Ko, Y.G. and Kim, S. (2002). p38 is essential for the assembly and stability of macromolecular tRNA synthetase complex: implications for its physiological significance. Proc. Natl. Acad. Sci. USA 99: 7912-6.
90. Kim, M.J., Park, B.J., Kang, Y.S., Kim, H. J., Park, J.H. Kang, J. W., Lee, S. W., Han, J. M., et al. (2003). Downregulation of fuse-binding protein and c-myc by tRNA synthetase cofactor, p38, is required for lung differentiation. Nat. Genet. 34: 330-6.
91. Kim, M.J., Yoo, Y.A., Kim, H.J., Kang, S., Kim, Y.G., Kim, J.S. and Yoo, Y.D. (2005). Mitochondrial ribosomal protein L41 mediates serum starvation-induced cell-cycle arrest through an increase of p21(WAF1/CIP1). Biochem. Biophys. Res. Commun. 338: 1179-84.
92. Kim, T., Park, S.G., Kim, J.E., Seol, W., Ko, Y.G. and Kim, S. (2000). Catalytic peptide of human glutaminyl-tRNA synthetase is essential for its assembly to the aminoacyl-tRNA synthetase complex. J. Biol. Chem. 275: 21768-72.
93. Kjellman, P., Lagercrantz, S., Hoog, A., Wallin, G., Larsson, C. and Zedenius, J. (2001). Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma. Genes Chromosomes Cancer 32: 43-9.
94. Ko, Y.G., Kang, Y.S., Kim, E.K., Park, S.G. and Kim, S. (2000). Nucleolar localization of human methionyl-tRNA synthetase and its role in ribosomal RNA synthesis. J. Cell Biol. 149: 567-74.
95. Ko, Y.G., Park, H. and Kim, S. (2002). Novel regulatory interactions and activities of mammalian tRNA synthetases. Proteomics 2: 1304-10.
96. Kraehn, G.M., Schartl, M. and Peter, R.U. (1995). Human malignant melanoma. A genetic disease? Cancer 75: 1228-37.
97. Krause, S.W., Rehli, M., Kreutz, M., Schwarzfischer, L., Paulauskis, J.D. and Andreesen, R. (1996). Differential screening identifies genetic markers of monocyte to macrophage maturation. J. Leukoc. Biol. 60: 540-5.
98. Kumar, K.U., Srivastava, S.P. and Kaufman, R.J. (1999). Double-stranded RNA-activated protein kinase (PKR) is negatively regulated by 60S ribosomal subunit protein L18. Mol. Cell Biol. 19: 1116-25.
99. Kuroki, T., Trapasso, F., Yendamuri, S., Matsuyama, A., Alder, H., Mori, M. and Croce, C.M. (2003). Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res. 63:3724-8.
100. Kushner, J.P., Boll, D., Quagliana, J. and Dickman, S. (1976). Elevated methionine-tRNA synthetase activity in human colon cancer. Proc. Soc. Exp. Biol. Med. 153: 273-6.
101. Lamberti, A., Caraglia, M., Longo, O., Marra, M., Abbruzzese, A. and Arcari, P. (2004). The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review article. Amino Acids 26: 443-8.
102. Lawrence, B., Perez-Atayde, A., Hibbard, M.K., Rubin, B.P., Dal Cin, P., Pinkus, J.L., Pinkus, G.S., Xiao, S., et al. (2000). TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am. J. Pathol. 157: 377-84.
103. Lazard, M., Mirande, M. and Waller, J.P. (1987). Expression of the aminoacyl-tRNA synthetase complex in cultured Chinese hamster ovary cells. Specific depression of the methionyl-tRNA synthetase component upon methionine restriction. J. Biol. Chem. 262: 3982-7.
104. Lee, S.W., Cho, B.H., Park, S.G. and Kim, S. (2004). Aminoacyl-tRNA synthetase complexes: beyond translation. J. Cell Sci. 117: 3725-34.
105. Lee, Y.S., Han, J.M., Kang, T., Park, Y.I., Kim, H.M. and Kim, S. (2006). Antitumor activity of the novel human cytokine AIMP1 in an in vivo tumor model. Mol. Cells 21: 213-7.
106. Lieber, M., Smith, B., Szakal, A., Nelson-Rees, W. and Todaro, G. (1976). A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer 17: 62-70.
107. Liu, H., Lo, C.R. and Czaja, M.J. (2002). NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 35: 772-8.
108. Liu, J., Shue, E., Ewalt, K.L. and Schimmel, P. (2004). A new gamma-interferon-inducible promoter and splice variants of an anti-angiogenic human tRNA synthetase. Nucl. Acids Res. 32: 719-27.
109. Loging, W.T. and Reisman, D. (1999). Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53. Cancer Epidemiol. Biomarkers Prev. 8: 1011-6.
110. Mager, W.H. (1988). Control of ribosomal protein gene expression. Biochim. Biophys. Acta. 949: 1-15.
111. Malta-Vacas, J., Aires, C., Costa, P., Conde, A.R., Ramos, S., Martins, A.P., Monteiro, C. and Brito, M. (2005). Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types. J. Clin. Pathol. 58: 621-5.
112. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S. and Ruco, L. (1992). The origin and function of tumor-associated macrophages. Immunol. Today 13: 265-70.
113. Marechal, V., Elenbaas, B., Piette, J., Nicolas, J.C. and Levine, A.J. (1994). The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell Biol. 14: 7414-20.
114. Markowitz, S.D. and Roberts, A.B. (1996). Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev. 7: 93-102.
115. Marten, N.W., Burke, E.J., Hayden, J.M. and Straus, D.S. (1994). Effect of amino acid limitation on the expression of 19 genes in rat hepatoma cells. FASEB J. 8: 538-44.
116. Mayeur, G.L., Fraser, C.S., Peiretti, F., Block, K.L. and Hershey, J.W. (2003). Characterization of eIF3k: a newly discovered subunit of mammalian translation initiation factor elF3. Eur. J. Biochem. 270: 4133-9.
117. Mayeur, G.L. and Hershey, J.W. (2002). Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e). FEBS Lett. 514: 49-54.
118. Menssen, A. and Hermeking, H. (2002). Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci. USA 99: 6274-9.
119. Meric, F. and Hunt, K.K. (2002). Translation initiation in cancer: a novel target for therapy. Mol. Cancer. Ther. 1: 971-9.
120. Michiels, L., Van der Rauwelaert, E., Van Hasselt, F., Kas, K. and Merregaert, J. (1993). fau cDNA encodes a ubiquitin-like-S30 fusion protein and is expressed as an antisense sequence in the Finkel-Biskis-Reilly murine sarcoma virus. Oncogene 8: 2537-46.
121. Mirande, M. (1991). Aminoacyl-tRNA synthetase family from prokaryotes and eukaryotes: structural domains and their implications. Prog Nucleic Acid Res. Mol. Biol. 40: 95-142.
122. Mittelman, F. (1991). Catalog of Chromosome Aberrations in Cancer. edited by Johansson, B. and Mertens, F., John Wiley and Sons.
123. Miyaki, M., Iijima, T., Shiba, K., Aki, T., Kita, Y., Yasuno, M., Mori, T., Kuroki, T., et al. (2001). Alterations of repeated sequences in 5′ upstream and coding regions in colorectal tumors from patients with hereditary nonpolyposis colorectal cancer and Turcot syndrome. Oncogene 20: 5215-8.
124. Miyazaki, S., Imatani, A., Ballard, L., Marchetti, A., Buttitta, F., Albertsen, H., Nevanlinna, H.A., Gallahan, D., et al. (1997). The chromosome location of the human homolog of the mouse mammary tumor-associated gene INT6 and its status in human breast carcinomas. Genomics 46: 155-8.
125. Moldave, K. (1985). Eukaryotic protein synthesis. Annu. Rev. Biochem. 54: 1109-49.
126. Morris, S.W., Naeve, C., Mathew, P., James, P.L., Kirstein, M.N., Cui, X. and Witte, D.P. (1997). ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14: 2175-88.
127. Mosyak, L., Reshetnikova, L., Goldgur, Y., Delarue, M. and Safro, M. G. (1995). Structure of phenylalanyl-tRNA synthetase from Thermus thermophilus. Nat. Struct. Biol. 2: 537-47.
128. Nadano, D., Aoki, C., Yoshinaka, T., Irie, S. and Sato, T.A. (2001). Electrophoretic characterization of ribosomal subunits and proteins in apoptosis: specific downregulation of S11 in staurosporine-treated human breast carcinoma cells. Biochemistry 40: 15184-93.
129. Nakamura, Y., Ito, K. and Isaksson, L.A. (1996). Emerging understanding of translation termination. Cell 87: 147-50.
130. Nakao, A., Yoshihama, M. and Kenmochi, N. K. (2004). RPG: the Ribosomal Protein Gene database. Nucl. Acids Res. 32: D168-70
131. Naora, H. (1999). Involvement of ribosomal proteins in regulating cell growth and apoptosis: translational modulation or recruitment for extraribosomal activity? Immunol. Cell Biol. 77: 197-205.
132. Neumann, F. and Krawinkel, U. (1997). Constitutive expression of human ribosomal protein L7 arrests the cell cycle in G1 and induces apoptosis in Jurkat T-lymphoma cells. Exp. Cell Res. 230: 252-61.
133. Nichols, R.C., Pai, S.I., Ge, Q., Targoff, I.N., Plotz, P.H. and Liu, P. (1995). Localization of two human autoantigen genes by PCR screening and in situ hybridization - glycyl-tRNA synthetase locates to 7p15 and alanyl-tRNA synthetase locates to 16q22. Genomics 30: 131-2.
134. Nicolaides, N.C., Kinzler, K.W. and Vogelstein, B. (1995). Analysis of the 5′ region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene. Genomics 29: 329-34.
135. Nilbert, M., Rydholm, A., Mitelman, F., Meltzer, P.S. and Mandahl, N. (1995). Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet. 83: 32-6.
136. Nupponen, N.N., Hyytinen, E.R., Kallioniemi, A.H. and Visakorpi, T. (1998). Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization. Cancer Genet. Cytogenet. 101: 53-7.
137. Oh, H.S., Kwon, H., Sun, S.K. and Yang, C.H. (2002). QM, a putative tumor suppressor, regulates proto-oncogene c-yes. J. Biol. Chem. 277: 36489-98.
138. Okamoto, H., Yasui, K., Zhao, C., Arii, S. and Inazawa, J. (2003). PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas. Hepatology 38: 1242-9.
139. Otani, A., Kinder, K., Ewalt, K., Otero, F.J., Schimmel, P. and Friedlander, M. (2002a). Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 8: 1004-10.
140. Otani, A., Slike, B.M., Dorrell, M.I., Hood, J., Kinder, K., Ewalt, K.L., Cheresh, D., Schimmel, P., et al. (2002b). A fragment of human TrpRS as a potent antagonist of ocular angiogenesis. Proc. Natl. Acad. Sci. USA 99: 178-83.
141. Paley, E.L., Alexandrova, N. and Smelansky, L. (1995). Tryptophanyl-tRNA synthetase as a human autoantigen. Immunol. Lett. 48: 201-7.
142. Paley, E.L., Smelyanski, L., Malinovskii, V., Subbarayan, P.R., Berdichevsky, Y., Posternak, N., Gershoni, J.M., Sokolova, O., et al. (2007). Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH(2) and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease. Mol. Immunol. 44: 541-57.
143. Palmer, J.L., Masui, S., Pritchard, S., Kalousek, D.K. and Sorensen, P.H. (1997). Cytogenetic and molecular genetic analysis of a pediatric pleomorphic sarcoma reveals similarities to adult malignant fibrous histiocytoma. Cancer Genet. Cytogenet. 95: 141-7.
144. Park, B.J., Kang, J.W., Lee, S.W., Choi, S.J., Shin, Y.K., Ahn, Y.H., Choi, Y.H., Choi, D., et al. (2005a). The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR. Cell 120: 209-21.
145. Park, S.G., Ewalt, K.L. and Kim, S. (2005b). Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. Trends Biochem. Sci. 30: 569-74
146. Park, B.J., Oh, Y.S., Park, S.Y., Choi, S.J., Rudolph, C., Schlegelberger, B. and Kim, S. (2006). AIMP3 haploinsufficiency disrupts oncogene-induced p53 activation and genomic stability. Cancer Res. 66: 6913-8.
147. Park, M.H., Joe, Y.A. and Kang, K.R. (1998). Deoxyhypusine synthase activity is essential for cell viability in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 273: 1677-83.
148. Park, S.G., Ewalt, K.L. and Kim, S. (2005b). Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. Trends Biochem. Sci. 30: 569-74.
149. Park, S.G., Kang, Y.S., Ahn, Y.H., Lee, S.H., Kim, K.R., Kim, K.W., Koh, G.Y., Ko, Y.G., et al. (2002). Dose-dependent biphasic activity of tRNA synthetase-associating factor, p43, in angiogenesis. J. Biol. Chem. 277: 45243-8.
150. Park, S.G., Kim, H.J., Min, Y.H., Choi, E.C., Shin, Y.K., Park, B.J., Lee, S.W. and Kim, S. (2005c). Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. Proc. Natl. Acad. Sci. USA 102: 6356-61.
151. Parker, M.T. and Gerner, E.W. (2002). Polyamine-mediated posttranscriptional regulation of COX-2. Biochimie 84: 815-9.
152. Pestova, T.V. and Hellen, C.U. (2001). Functions of eukaryotic factors in initiation of translation. Cold. Spring. Harb. Symp. Quant. Biol. 66: 389-96.
153. Rajasekhar, V.K. and Holland, E.C. (2004). Postgenomic global analysis of translational control induced by oncogenic signaling. Oncogene 23: 3248-64.
154. Reifenberger, G., Ichimura, K., Reifenberger, J., Elkahloun, A.G., Meltzer, P.S. and Collins, V.P. (1996). Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res. 56: 5141-5.
155. Rho, S.B., Lee, K.H., Kim, J.W., Shiba, K., Jo, Y.J. and Kim, S. (1996). Interaction between human tRNA synthetases involves repeated sequence elements. Proc. Natl. Acad Sci. USA 93: 10128-33.
156. Rhoads, R.E. (1999). Signal transduction pathways that regulate eukaryotic protein synthesis. J. Biol. Chem. 274: 30337-40.
157. Rodova, M., Ankilova, V. and Sasfro, M.G. (1999). Human phenylalanyl-tRNA synthetase: cloning, characterization of the deduced amino acid sequences in terms of the structural domains and coordinately regulated expression of the alpha and beta subunits in chronic myeloid leukemia cells. Biochem. Biophys. Red. Commun. 255: 765-73.
158. Rosenwald, I.B. (1996). Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2alpha in transformed cells. Cancer Lett. 102: 113-23.
159. Rossman, T.G. and Wang, Z. (1999). Expression cloning for arsenite-resistance resulted in isolation of tumor-suppressor fau cDNA: possible involvement of the ubiquitin system in arsenic carcinogenesis. Carcinogenesis 20: 311-6.
160. Rothe, M., Ko, Y., Albers, P. and Wernert, N. (2000). Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas. Am. J. Pathol. 157: 1597-604.
161. Ruggero, D. and Pandolfi, P.P. (2003). Does the ribosome translate cancer? Nat. Rev. Cancer 3: 179-92.
162. Salvucci, O., Basik, M., Yao, L., Bianchi, R. and Tosato, G. (2004). Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma. J. Leukoc. Biol. 76: 217-26.
163. Saramaki, O., Willi, N., Bratt, O., Gasser, T.C., Koivisto, P., Nupponen, N.N., Bubendorf, L. and Visakorpi, T. (2001). Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer. Am. J. Pathol. 159: 2089-94.
164. Sato, K., Qian, J., Slezak, J.M., Lieber, M.M., Bostwick, D.G., Bergstralh, E.J. and Jenkins, R.B. (1999). Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J. Natl. Cancer Inst. 91: 1574-80.
165. Savinainen, K.J., Linja, M.J., Saramaki, O.R., Tammela, T.L., Chang, G.T., Brinkmann, A.O. and Visakorpi, T. (2004). Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer. Br. J. Cancer 90: 1041-6.
166. Scandurro, A.B., Weldon, C.W., Figueroa, Y.G., Alam, J. and Beckman, B.S. (2001). Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. Int. J. Oncol. 19: 129-35.
167. Schimmel, P. (1987). Aminoacyl tRNA synthetases: general scheme of structure-function relationships in the polypeptides and recognition of transfer RNAs. Annu. Rev. Biochem. 56: 125-58.
168. Schlumberger, M.J. (1998). Papillary and follicular thyroid carcinoma. N. Engl. J. Med. 338: 297-306.
169. Schmidt, M., Schler, G., Gruensfelder, P. and Hoppe, F. (2006). Differential gene expression in a paclitaxel-resistant clone of a head and neck cancer cell line. Eur. Arch. Otorhinolaryngol. 263: 127-34.
170. Schwarz, M.A., Kandel, J., Brett, J., Li, J., Hayward, J., Schwarz, R.E., Chappey, O., Wautier, J., et al. (1999). Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J. Exp. Med. 190: 341-54.
171. Sen, S., Zhou, H., Ripmaster, T., Hittelman, W.N., Schimmel, P. and White, R.A. (1997). Expression of a gene encoding a tRNA synthetase-like protein is enhanced in tumorigenic human myeloid leukemia cells and is cell cycle stage- and differentiation-dependent. Proc. Natl. Acad. Sci. USA 94: 6164-9.
172. Shen, D.W., Liang, X.J., Suzuki, T. and Gottesman, M.M. (2006). Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and the 10-kDa heat shock protein that confer cisplatin resistance. Mol. Pharmacol. 69: 1383-8.
173. Shi, X.P., Yin, K.C., Zimolo, Z.A., Stern, A.M. and Waxman, L. (1996). The subcellular distribution of eukaryotic translation initiation factor, eIF-5A, in cultured cells. Exp. Cell Res. 225: 348-56.
174. Shi, Y., Zhai, H., Wang, X., Han, Z., Liu, C., Lan, M., Du, J., Guo, C., et al. (2004). Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis. Exp. Cell Res. 296: 337-46.
175. Steinkasserer, A., Jones, T., Sheer, D., Koettnitz, K., Hauber, J. and Bevec, D. (1995). The eukaryotic cofactor for the human immunodeficiency virus type 1 (HIV-1) rev protein, eIF-5A, maps to chromosome 17p12-p13: three eIF-5A pseudogenes map to 10q23.3, 17q25, and 19q13.2. Genomics 25: 749-52.
176. Su, Z., Goldstein, N.I. and Fisher, P.B. (1998). Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes. Proc. Natl. Acad. Sci. USA 95: 1764-9.
177. Summersgill, B., Goker, H., Weber-Hall, S., Huddart, R., Horwich, A. and Shipley, J. (1998). Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. Br. J. Cancer 77: 305-13.
178. Suzuki, K., Ogura, T., Yokose, T., Nagai, K., Mukai, K., Kodama, T., Nishiwaki, Y. and Esumi, H. (1998). Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia. Int. J. Cancer 79: 384-9.
179. Taira, H., Ejiri, S. and Shimura, K. (1972). Purification and some properties of G-factor from the silk gland of silkworm. J. Biochem. (Tokyo) 72: 1527-35.
180. Thornton, S., Anand, N., Purcell, D. and Lee, J. (2003). Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis. J. Mol. Med. 81: 536-48.
181. Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., et al. (2001). ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2: 222-8.
182. Tran, N., Bharaj, B.S., Diamandis, E.P., Smith, M., Li, B.D. and Yu, H. (2004). Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings. Cancer Epidemiol. Biomarkers Prev. 13: 2133-40.
183. Tsujitani, S., Shirai, H., Tatebe, S., Sugamura, K., Ohfuji, S., Gomyo, Y., Maeta, M., Ito, H., et al. (1996). Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma. Cancer 77: 1711-6.
184. Turpaev, K.T., Zakhariev, V.M., Sokolova, I.V., Narovlyansky, A.N., Amchenkova, A.M., Justesen, J. and Frolova, L.Y. (1996). Alternative processing of the tryptophanyl-tRNA synthetase mRNA from interferon-treated human cells. Eur. J. Biochem. 240: 732-7.
185. Tzima, E., Reader, J.S., Irani-Tehrani, M., Ewalt, K.L., Schwartz, M.A. and Schimmel, P. (2003). Biologically active fragment of a human tRNA synthetase inhibits fluid shear stress-activated responses of endothelial cells. Proc. Natl. Acad. Sci. USA 100: 14903-7.
186. Tzima, E., Reader, J.S., Irani-Tehrani, M., Ewalt, K.L., Schwartz, M.A. and Schimmel, P. (2005). VE-cadherin links tRNA synthetase cytokine to anti-angiogenic function. J. Biol. Chem. 280: 2405-8.
187. Ubeda, M., Schmitt-Ney, M., Ferrer, J. and Habener, J.F. (1999). CHOP/GADD153 and methionyl-tRNA synthetase (MetRS) genes overlap in a conserved region that controls mRNA stability. Biochem. Biophys. Res. Commun. 262: 31-8.
188. Usselmann, B., Newbold, M., Morris, A.G. and Nwokolo, C.U. (2001). Telomerase activity and patient survival after surgery for gastric and oesophageal cancer. Eur. J. Gastroenterol. Hepatol. 13: 903-8.
189. Uzawa, N., Yoshida, M.A., Oshimura, M. and Ikeuchi, T. (1995). Suppression of tumorigenicity in three different cell lines of human oral squamous cell carcinoma by introduction of chromosome 3p via microcell-mediated chromosome transfer. Oncogene 11: 1997-2004.
190. Visakorpi, T. (2003). The molecular genetics of prostate cancer. Urology 62: 3-10.
191. Wakasugi, K., Slike, B.M., Hood, J., Ewalt, K.L., Cheresh, D.A. and Schimmel, P. (2002a). Induction of angiogenesis by a fragment of human tyrosyl-tRNA synthetase. J. Biol. Chem. 277: 20124-6.
192. Wakasugi, K., Slike, B.M., Hood, J., Otani, A., Ewalt, K.L., Friedlander, M., Cheresh, D.A. and Schimmel, P. (2002b). A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc. Natl. Acad. Sci. USA 99: 173-7.
193. Wang, T.W., Lu, L., Wang, D. and Thompson, J.E. (2001). Isolation and characterization of senescence-induced cDNAs encoding deoxyhypusine synthase and eucaryotic translation initiation factor 5A from tomato. J. Biol. Chem. 276: 17541-9.
194. Wasenius, V.M., Hemmer, S., Kettunen, E., Knuutila, S., Franssila, K. and Joensuu, H. (2003). Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Clin. Cancer Res. 9: 68-75.
195. Watkins, S.J. and Norbury, C.J. (2004). Cell cycle-related variation in subcellular localization of eIF3e/INT6 in human fibroblasts. Cell Prolif. 37: 149-160.
196. Wiesenthal, V., Leutz, A. and Calkhoven, C.F. (2006). A translation control reporter system (TCRS) for the analysis of translationally controlled processes in the vertebrate cell. Nucl. Acids Res. 34: e23.
197. Wilkinson, M.F. and Shyu, A.B. (2001). Multifunctional regulatory proteins that control gene expression in both the nucleus and the cytoplasm. Bioessays. 23: 775-787.
198. Woese, C. (1998). The universal ancestor. Proc. Natl. Acad. Sci. USA 95: 6854-9.
199. Wool, I.G. (1996). Extraribosomal functions of ribosomal proteins. Trends Biochem. Sci. 21: 164-5.
200. Wool, I.G., Chan, Y.L. and Gluck, A. (1990). Structure, fuction, and evolution of mammalian ribosomes. In The Ribosome. Structure, Fuction, and Evolution. American Society for Microbiology.
201. Xu, X.L., Wu, L.C., Du, F., Davis, A., Peyton, M., Tomizawa, Y., Maitra, A., Tomlinson, G., et al. (2001). Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res. 61: 7943-9.
202. Yan, R. and Rhoads, R.E. (1995). Human protein synthesis initiation factor eIF-4 gamma is encoded by a single gene (EIF4G) that maps to chromosome 3q27-qter. Genomics 26: 394-8.
203. Yoo, Y.A., Kim, M.J., Park, J.K., Chung, Y.M., Lee, J.H., Chi, S.G., Kim, J.S. and Yoo, Y.D. (2005). Mitochondrial ribosomal protein L41 suppresses cell growth in association with p53 and p27Kip1. Mol. Cell Biol. 25: 6603-16.
204. Young, M.R. and Wright, M.A. (1992). Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis. Cancer Res. 52: 6335-40.
205. Yousem, S.A., Shaw, H. and Cieply, K. (2001). Involvement of 2p23 in pulmonary inflammatory pseudotumors. Hum. Pathol. 32: 428-33.
206. Zhang, J., Zheng, S., Gao, Y., Rotolo, J.A., Xiao, Z., Li, C. and Cheng, S. (2004). A partial allelotyping of urothelial carcinoma of bladder in the Chinese. Carcinogenesis 25: 343-7.
207. Zhang, L., Pan, X. and Hershey, J.W. (2007). Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J. Biol. Chem. 28: 25790-800.
208. Zhao, Y., You, H., Liu, F., An, H., Shi, Y., Yu, Q. and Fan, D. (2002). Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett. 185: 211-8.